PhaseBio Pharmaceuticals, Inc.

PhaseBio Pharmaceuticals, Inc.

PhaseBio Pharmaceuticals, Inc.

Overview
Date Founded

2002

Headquarters

3500 South Dupont Highway,Kent County,Dover, DE 19901

Type of Company

Public

Employees (Worldwide)

50

Industries

Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiopulmonary diseases. The firm's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor; pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension; and PB6440, an oral agent for the treatment of resistant hypertension. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp on January 10, 2002 and is headquartered in Malvern, PA.

Contact Data
Trying to get in touch with decision makers at PhaseBio Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Director

Chief Financial Officer & Principal Accounting Officer

Chief Medical Officer

Vice President of Preclinical & CMC

Vice President of Corporate Development & Commercial Strategy

Vice President of Research & Scientific Affairs

Vice President of Human Resources

Co-Founder

Research Director

Director of Marketing

Paths to PhaseBio Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
PhaseBio Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Details Hidden

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Recent Transactions
Details Hidden

PhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

PhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

PhaseBio Pharmaceuticals, Inc. raised money in a private placement transaction

Transaction Advisors
Underwriter

Advised onPhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Escrow Agent

Advised onPhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onPhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onPhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onPhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Associate

Advised onPhaseBio Pharmaceuticals, Inc. issued USD Common Stock

Advisors & Consultants
Medical Advisor

Member, Advisory Board at Incarda Therapeutics, Inc.

Medical Advisor

Acting Medical Director at Xeris Pharmaceuticals, Inc.

Medical Advisor

Member, Advisory Board at Symplmed Pharmaceuticals LLC

Clients

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

Immunoforge Co. Ltd. provides solutions for sarcopenia based on drug repurposing patents. The company was founded by Sung-Min Ahn and Kiho Chang on May 29, 2017 and is headquartered in Seoul, South Korea.

Key Stats and Financials As of 2020
Market Capitalization
$99.5M
Total Enterprise Value
$83.6M
Earnings Per Share
$-3.39
Revenue
$0
Net Profit
$-98.6M
EBITDA
$-84.7M
Total Debt
$14.1M
Total Equity
$-25.2M
TEVNet Income
-0.85x
Debt TEV
0.17x
Investments
Details Hidden

Immunoforge Co. Ltd. provides solutions for sarcopenia based on drug repurposing patents. The company was founded by Sung-Min Ahn and Kiho Chang on May 29, 2017 and is headquartered in Seoul, South Korea.

Investors
Details Hidden

Cormorant invests in companies primarily located in North America. The firm targets companies in sectors such as life-science and biotech. It provides financing for early stage capital requirements.

Details Hidden

Mountain Group Partners (“MGP”) is an investor dedicated to investing in and actively guiding transformational businesses in the Life Sciences and Technology sectors. Founded in 2002, MGP principals have invested in more than 30 companies in these sectors.Currently, MGP is investing funds from (1) MGC Venture Partners 2013, LP, (2) Limestone Fund, a fund chosen in 2009 by the State of Tennessee to invest state funds to drive economic growth in Tennessee, and (3) private capital accounts.Mountain Group Partners seeks to invest in seed and early stage companies focused on two major sectors: Life Sciences and Technology. Within the Life Sciences sector, the Fund primarily focuses on investments in the diagnostics, medical device, and nutraceuticals & expedited drug development sub-sectors. Within the Technology sector, the Fund has a concentration in healthcare technology, business services and consumer technology companiesMountain Group Partners seeks to invest in Small/Middle Market Companies ?MGP targets private businesses or divisions of companies typically with revenue between $1 million and $10 million•History of Cash Flow ?Acquisition candidates should have a history of strong cash flow•Quality Management Teams ?MGP seeks to partner with strong management teams that have a proven record of success and who wish to become co-owners with MGP•Basic Industries ?Manufacturing, distribution and basic service companies with strong market shares in focused niches are targeted.

Details Hidden

Co-Founder at Hatteras Venture Partners

Suppliers
AstraZeneca Plc Other Manufacturing | Cambridge, United Kingdom

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Wacker Chemie AG Hospitals & Patient Services | Munich, Germany

Wacker Chemie AG engages in the manufacture and distribution of chemical products. It operates through the following segments: Silicones, Polymers, Biosolutions, Polysilicons, and Other. The Silicones segment includes silicones and silicone rubber for consumer goods, chemicals, energy and electronics applications, and construction products. The Polymers segment produces dispersions and dispersible polymer powders. The Biosolutions segment fabricates fine chemicals, such as proteins, cyclodextirins, cysteine, and acetate solid resins. The Polysilicon segment consists of hyperpure polysilicon, chlorosilanes, and pyrogenic silicas for the semiconductor and electronics industries. The Others segments comprises of other activities. The company was founded on October 13, 1914 and is headquartered in Munich, Germany.

Duke University Publishing | Durham, NC

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

United Therapeutics Corp. Pharmaceuticals - Silver Spring, Maryland

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by PhaseBio Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of PhaseBio Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and PhaseBio Pharmaceuticals, Inc..